Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00592657 · ClinicalTrials.gov registry record

Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions

A clinical trial, sponsored by Akron Children's Hospital.

Completed
Registry status
46
Enrollment target

NCT00592657 is a clinical trial that has completed, run by Akron Children's Hospital. The registered enrollment target is 46 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00592657 has completed, sponsored by Akron Children's Hospital.

COMPLETED
Registry status
46 participants
Enrollment target

Study Summary

Retrospective chart review to determine the presence of rhabdomyolysis among patients admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2008-01
Est. Completion 2008-04

Sponsor

Akron Children's Hospital

27 total trials

What the Registry Record Tells You About NCT00592657

The ClinicalTrials.gov registry entry for NCT00592657 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00592657 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00592657 about?

NCT00592657 is a clinical study titled "Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions". Retrospective chart review to determine the presence of rhabdomyolysis among patients admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.

What is the current status of trial NCT00592657?

This trial is currently completed. The enrollment target is 46 participants. The study started on 2008-01. Estimated completion is 2008-04.

Who is sponsoring clinical trial NCT00592657?

This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.